Press release
Acute Ischemic Stroke Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies, Mechanism of Action, Route of Administration, and Companies by DelveInsight
(Albany, USA) As per DelveInsight's assessment, globally, about 35+ key pharma and biotech companies are working on 35+ pipeline drugs in the Acute Ischemic Stroke therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
"Acute Ischemic Stroke Pipeline Insight 2024" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Acute Ischemic Stroke Therapeutics Market.
The report provides a detailed description of the Acute Ischemic Stroke drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Acute Ischemic Stroke Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/acute-ischemic-stroke-ais-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key Takeaways from the Acute Ischemic Stroke Pipeline Report
• In November 2024:- Shanghai Hutchison Pharmaceuticals Limited- This study is a Phase II, multicenter, randomized, double Blind, placebo-Controlled design. Participants receive twice daily dosing for 7 consecutive days, or once on Days 1 and Day 8 and twice daily on Days 2 to Day 7, with each subject scheduled to receive 14 doses throughout the clinical trial. 270 Participants will be randomized 1:1:1 to SHPL-49 injection treated group (3 ampoules of SHPL-49 injections, BID), SHPL-49 injection treated group (6 ampoules of SHPL-49 injections , BID) and placebo group (BID).
• DelveInsight's Acute Ischemic Stroke pipeline report depicts a robust space with 180+ active players working to develop 200+ pipeline therapies for Acute Ischemic Stroke treatment.
• The leading Acute Ischemic Stroke Companies such as Tasly Pharmaceutical, Revalesio Corporation, Avilex Pharma, GNT Pharma, Biogen, AptaTargets, NC Medical Research, Prolong Pharmaceuticals, Saillant Therapeutics, TargED Biopharmaceuticals and others.
• Promising Acute Ischemic Stroke therapies such as Sovateltide, Tenecteplase, BB-031, hUCB, LT3001, Elezanumab, Redasemtide, Cerebrolysin, SP-8203 , and others.
Acute Ischemic Stroke Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Acute Ischemic Stroke therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Acute Ischemic Stroke treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Acute Ischemic Stroke drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Acute Ischemic Stroke treatment market.
Learn More about the Clinical and Commercial Development Activities in the Acute Ischemic Stroke Therapeutics Domain @
https://www.delveinsight.com/report-store/acute-ischemic-stroke-ais-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Acute Ischemic Stroke Therapeutics Analysis
Over 35+ pharma and biotech companies are actively involved in the development of therapies for Acute Ischemic Stroke. Notably, GNT Pharma stands out among them, with Acute Ischemic Stroke drug candidates progressing to the most advanced stage, namely phase III of clinical trials. The diverse landscape of companies reflects the collective dedication to advancing innovative solutions for Acute Ischemic Stroke and underscores the promising advancements in the field of treatment for this medical condition.
Acute Ischemic Stroke Companies in the Therapeutics Market Include:
Some of the key companies in the Acute Ischemic Stroke Market include Genentech, Supergene, Tasly Pharmaceutical, Pharmazz, GNT Pharma, NoNO, Angde Biotech Pharmaceutical, NuvOx Pharma, Healios, Acticor Biotech, Biogen, ZZ Biotech, Revalesio Corporation, Shionogi & Co., Ltd., AbbVie, Pharming Group, Bristol-Myers Squibb, Roche, Clinuvel Pharmaceuticals, TrueBinding, ShinPoong Pharmaceutical, Lumosa Therapeutics, NC Medical Research, JCR Pharmaceuticals, aptaTargets, PT. Prodia Stem Cell Indonesia, and many others.
Emerging and Marketed Acute Ischemic Stroke Therapies Covered in the Report Include:
• Nelonemdaz: GNT Pharma
• Tenecteplase: Genentech
• SP-8203: Shin Poong Pharmaceutical
• NONO-SC: NoNO Inc.
• Glenzocimab: Acticor Biotech
• DM199: DiaMedica Therapeutics
• LT3001: Lumosa Therapeutics
• Nerinetide: NoNO Inc.
• BMS-986177/milvexian: Bristol Myers Squibb Company/Janssen Pharmaceuticals
• Invimestrocel: Healios/Athersys
And Many More
Get an in-depth Assessment of the Emerging Therapies and Acute Ischemic Stroke Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/acute-ischemic-stroke-ais-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
The Report Covers the Emerging Acute Ischemic Stroke Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates
Route of Administration
Acute Ischemic Stroke pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Acute Ischemic Stroke Products have been categorized under various ROAs such as
• Intravenous
• Subcutaneous
• Oral
• Intramuscular
Molecule Type
Acute Ischemic Stroke Products have been categorized under various Molecule types such as
• Monoclonal antibody
• Small molecule
• Peptide
Request for Sample PDF to Understand More About the Acute Ischemic Stroke Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/acute-ischemic-stroke-ais-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Content
1. Report Introduction
2. Executive Summary
3. Acute Ischemic Stroke Current Treatment Patterns
4. Acute Ischemic Stroke - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Acute Ischemic Stroke Late-Stage Products (Phase-III)
7. Acute Ischemic Stroke Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Acute Ischemic Stroke Discontinued Products
13. Acute Ischemic Stroke Product Profiles
14. Acute Ischemic Stroke Companies
15. Acute Ischemic Stroke Drugs
16. Dormant and Discontinued Products
17. Acute Ischemic Stroke Unmet Needs
18. Acute Ischemic Stroke Future Perspectives
19. Acute Ischemic Stroke Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/acute-ischemic-stroke-ais-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Trending Reports:
• Acute Pain Market: https://www.delveinsight.com/report-store/acute-pain-market
• Alopecia Aerata Market: https://www.delveinsight.com/report-store/alopecia-areata-market
• Bone Anchored Hearing Systems Market: https://www.delveinsight.com/report-store/bone-anchored-hearing-systems-market
• Neuromodulation Devices Market: https://www.delveinsight.com/report-store/neuromodulation-devices-market
• Prefilled Syringes Market: https://www.delveinsight.com/report-store/prefilled-syringes-market
• Abetalipoproteinemia Market: https://www.delveinsight.com/report-store/abetalipoproteinemia-market
• Parkinson's Disease Market: https://www.delveinsight.com/report-store/parkinsons-disease-market-size-analysis-treatment
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
• Brain Cancer Market: https://www.delveinsight.com/report-store/brain-cancer-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Adult Growth Hormone Deficiency Market: https://www.delveinsight.com/report-store/adult-growth-hormone-deficiency-aghd-market
• Biliary Tumor Market: https://www.delveinsight.com/report-store/biliary-tumor-market
• Xerostomia Market: https://www.delveinsight.com/report-store/xerostomia-market
• Emesis Market: https://www.delveinsight.com/report-store/emesis-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/hearing-aid-devices-market
• Reactive Arthritis Market: https://www.delveinsight.com/report-store/reactive-arthritis-market
• Defibrillators Market: https://www.delveinsight.com/report-store/defibrillator-market
• Airway Stent Market Market: https://www.delveinsight.com/report-store/airway-stent-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market
• Asphyxia Market: https://www.delveinsight.com/report-store/asphyxia-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Vitamin A Deficiency Market: https://www.delveinsight.com/report-store/vitamin-a-deficiency-market
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
"Acute Ischemic Stroke Pipeline Insight 2024" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Acute Ischemic Stroke Therapeutics Market.
The report provides a detailed description of the Acute Ischemic Stroke drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Acute Ischemic Stroke Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/acute-ischemic-stroke-ais-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key Takeaways from the Acute Ischemic Stroke Pipeline Report
• In November 2024:- Shanghai Hutchison Pharmaceuticals Limited- This study is a Phase II, multicenter, randomized, double Blind, placebo-Controlled design. Participants receive twice daily dosing for 7 consecutive days, or once on Days 1 and Day 8 and twice daily on Days 2 to Day 7, with each subject scheduled to receive 14 doses throughout the clinical trial. 270 Participants will be randomized 1:1:1 to SHPL-49 injection treated group (3 ampoules of SHPL-49 injections, BID), SHPL-49 injection treated group (6 ampoules of SHPL-49 injections , BID) and placebo group (BID).
• DelveInsight's Acute Ischemic Stroke pipeline report depicts a robust space with 180+ active players working to develop 200+ pipeline therapies for Acute Ischemic Stroke treatment.
• The leading Acute Ischemic Stroke Companies such as Tasly Pharmaceutical, Revalesio Corporation, Avilex Pharma, GNT Pharma, Biogen, AptaTargets, NC Medical Research, Prolong Pharmaceuticals, Saillant Therapeutics, TargED Biopharmaceuticals and others.
• Promising Acute Ischemic Stroke therapies such as Sovateltide, Tenecteplase, BB-031, hUCB, LT3001, Elezanumab, Redasemtide, Cerebrolysin, SP-8203 , and others.
Acute Ischemic Stroke Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Acute Ischemic Stroke therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Acute Ischemic Stroke treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Acute Ischemic Stroke drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Acute Ischemic Stroke treatment market.
Learn More about the Clinical and Commercial Development Activities in the Acute Ischemic Stroke Therapeutics Domain @
https://www.delveinsight.com/report-store/acute-ischemic-stroke-ais-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Acute Ischemic Stroke Therapeutics Analysis
Over 35+ pharma and biotech companies are actively involved in the development of therapies for Acute Ischemic Stroke. Notably, GNT Pharma stands out among them, with Acute Ischemic Stroke drug candidates progressing to the most advanced stage, namely phase III of clinical trials. The diverse landscape of companies reflects the collective dedication to advancing innovative solutions for Acute Ischemic Stroke and underscores the promising advancements in the field of treatment for this medical condition.
Acute Ischemic Stroke Companies in the Therapeutics Market Include:
Some of the key companies in the Acute Ischemic Stroke Market include Genentech, Supergene, Tasly Pharmaceutical, Pharmazz, GNT Pharma, NoNO, Angde Biotech Pharmaceutical, NuvOx Pharma, Healios, Acticor Biotech, Biogen, ZZ Biotech, Revalesio Corporation, Shionogi & Co., Ltd., AbbVie, Pharming Group, Bristol-Myers Squibb, Roche, Clinuvel Pharmaceuticals, TrueBinding, ShinPoong Pharmaceutical, Lumosa Therapeutics, NC Medical Research, JCR Pharmaceuticals, aptaTargets, PT. Prodia Stem Cell Indonesia, and many others.
Emerging and Marketed Acute Ischemic Stroke Therapies Covered in the Report Include:
• Nelonemdaz: GNT Pharma
• Tenecteplase: Genentech
• SP-8203: Shin Poong Pharmaceutical
• NONO-SC: NoNO Inc.
• Glenzocimab: Acticor Biotech
• DM199: DiaMedica Therapeutics
• LT3001: Lumosa Therapeutics
• Nerinetide: NoNO Inc.
• BMS-986177/milvexian: Bristol Myers Squibb Company/Janssen Pharmaceuticals
• Invimestrocel: Healios/Athersys
And Many More
Get an in-depth Assessment of the Emerging Therapies and Acute Ischemic Stroke Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/acute-ischemic-stroke-ais-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
The Report Covers the Emerging Acute Ischemic Stroke Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates
Route of Administration
Acute Ischemic Stroke pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Acute Ischemic Stroke Products have been categorized under various ROAs such as
• Intravenous
• Subcutaneous
• Oral
• Intramuscular
Molecule Type
Acute Ischemic Stroke Products have been categorized under various Molecule types such as
• Monoclonal antibody
• Small molecule
• Peptide
Request for Sample PDF to Understand More About the Acute Ischemic Stroke Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/acute-ischemic-stroke-ais-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Content
1. Report Introduction
2. Executive Summary
3. Acute Ischemic Stroke Current Treatment Patterns
4. Acute Ischemic Stroke - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Acute Ischemic Stroke Late-Stage Products (Phase-III)
7. Acute Ischemic Stroke Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Acute Ischemic Stroke Discontinued Products
13. Acute Ischemic Stroke Product Profiles
14. Acute Ischemic Stroke Companies
15. Acute Ischemic Stroke Drugs
16. Dormant and Discontinued Products
17. Acute Ischemic Stroke Unmet Needs
18. Acute Ischemic Stroke Future Perspectives
19. Acute Ischemic Stroke Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/acute-ischemic-stroke-ais-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Trending Reports:
• Acute Pain Market: https://www.delveinsight.com/report-store/acute-pain-market
• Alopecia Aerata Market: https://www.delveinsight.com/report-store/alopecia-areata-market
• Bone Anchored Hearing Systems Market: https://www.delveinsight.com/report-store/bone-anchored-hearing-systems-market
• Neuromodulation Devices Market: https://www.delveinsight.com/report-store/neuromodulation-devices-market
• Prefilled Syringes Market: https://www.delveinsight.com/report-store/prefilled-syringes-market
• Abetalipoproteinemia Market: https://www.delveinsight.com/report-store/abetalipoproteinemia-market
• Parkinson's Disease Market: https://www.delveinsight.com/report-store/parkinsons-disease-market-size-analysis-treatment
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
• Brain Cancer Market: https://www.delveinsight.com/report-store/brain-cancer-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Adult Growth Hormone Deficiency Market: https://www.delveinsight.com/report-store/adult-growth-hormone-deficiency-aghd-market
• Biliary Tumor Market: https://www.delveinsight.com/report-store/biliary-tumor-market
• Xerostomia Market: https://www.delveinsight.com/report-store/xerostomia-market
• Emesis Market: https://www.delveinsight.com/report-store/emesis-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/hearing-aid-devices-market
• Reactive Arthritis Market: https://www.delveinsight.com/report-store/reactive-arthritis-market
• Defibrillators Market: https://www.delveinsight.com/report-store/defibrillator-market
• Airway Stent Market Market: https://www.delveinsight.com/report-store/airway-stent-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market
• Asphyxia Market: https://www.delveinsight.com/report-store/asphyxia-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Vitamin A Deficiency Market: https://www.delveinsight.com/report-store/vitamin-a-deficiency-market
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
